Pasithea Therapeutics (KTTA)
(Delayed Data from NSDQ)
$0.73 USD
+0.01 (1.86%)
Updated Sep 19, 2025 04:00 PM ET
After-Market: $0.71 -0.02 (-3.15%) 7:58 PM ET
NA Value
NA Growth NA Momentum NA VGMFundamental Charts
About PEG Ratio (TTM)
The company's trailing twelve month (TTM) PEG ratio is the P/E ratio divided by its long-term growth rate consensus. This ratio essentially compares the P/E to its growth rate, thus, for many, telling a more complete story than just the P/E ratio alone. Conventional wisdom says that a PEG ratio of 1 or less is considered good (at par or undervalued to its growth rate). A value greater than 1, in general, is not as good (overvalued to its growth rate). For example, a company with a P/E ratio of 25 and a growth rate of 20% would have a PEG ratio of 1.25 (25 / 20 = 1.25). A company with a P/E ratio of 40 and a growth rate of 50% would have a PEG ratio of 0.80 (40 / 50 = 0.80). Traditionally, investors would look at the stock with the lower P/E and deem it a bargain. But when compared to its growth rate, it doesn't have the earnings growth to justify its P/E. In this example, the one with the P/E of 40 is the better bargain because it is selling at a discount to its growth rate. So the PEG ratio tells you what you're paying for each unit of earnings growth.
KTTA 0.73 +0.01(1.86%)
Will KTTA be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for KTTA based on the 1-3 month trading system that more than doubles the S&P 500.
Other News for KTTA
Is KTTA heading for a slide? Stochastic Reached Oversold shows up after a relatively flat session
12 Health Care Stocks Moving In Friday's After-Market Session
Fell Below 50 Day Moving Average appears for KTTA after 3.22% move
50 Day Moving Average Support appears for KTTA after 3.22% move
Is KTTA positioned for a breakout? 20 Day Moving Average Support shows up after slipping 0.23%